OBJECTIVE: To evaluate the relationship between long-term maintenance of moderate to vigorous physical activity (MVPA) and clinical outcomes in fibromyalgia (FM). METHODS:Patients with FM (n = 170) receivedindividualized exercise prescriptions and completed baseline and followup physical activity assessments using the Community Health Activities Model Program for Seniors questionnaire at weeks 12, 24, and 36. The primary outcome was the change in the Fibromyalgia Impact Questionnaire-Physical Impairment (FIQ-PI) score. The secondary outcomes included improvements in overall well-being (FIQ total score), pain severity ratings, and depression. RESULTS: Using a threshold increase in MVPA of ≥10 metabolic equivalent hours/week above usual activities, 27 subjects (15.9%) increased and sustained (SUS-PA), 68 (40%) increased but then declined (UNSUS-PA), and 75 (44.1%) did not achieve (LO-PA) this benchmark. Compared to LO-PA subjects, both SUS-PA and UNSUS-PA subjects reported greater improvement in FIQ-PI (P < 0.01) and FIQ total score (P < 0.05). Additionally, the SUS-PA group reported greater improvement in pain severity compared to the LO-PA group (P < 0.05). However, there were no significant group differences between SUS-PA and UNSUS-PA for any primary or secondary outcome measure. CONCLUSION: Increased participation in MVPA for at least 12 weeks improved physical function and overall well-being in patients with FM. Although sustained physical activity was not associated with greater clinical benefit compared with unsustained physical activity, these findings also suggest that performing greater volumes of physical activity is not associated with worsening pain in FM. Future research is needed to determine the relationship between sustained MVPA participation and subsequent improvement in patient outcomes.
RCT Entities:
OBJECTIVE: To evaluate the relationship between long-term maintenance of moderate to vigorous physical activity (MVPA) and clinical outcomes in fibromyalgia (FM). METHODS:Patients with FM (n = 170) received individualized exercise prescriptions and completed baseline and followup physical activity assessments using the Community Health Activities Model Program for Seniors questionnaire at weeks 12, 24, and 36. The primary outcome was the change in the Fibromyalgia Impact Questionnaire-Physical Impairment (FIQ-PI) score. The secondary outcomes included improvements in overall well-being (FIQ total score), pain severity ratings, and depression. RESULTS: Using a threshold increase in MVPA of ≥10 metabolic equivalent hours/week above usual activities, 27 subjects (15.9%) increased and sustained (SUS-PA), 68 (40%) increased but then declined (UNSUS-PA), and 75 (44.1%) did not achieve (LO-PA) this benchmark. Compared to LO-PA subjects, both SUS-PA and UNSUS-PA subjects reported greater improvement in FIQ-PI (P < 0.01) and FIQ total score (P < 0.05). Additionally, the SUS-PA group reported greater improvement in pain severity compared to the LO-PA group (P < 0.05). However, there were no significant group differences between SUS-PA and UNSUS-PA for any primary or secondary outcome measure. CONCLUSION: Increased participation in MVPA for at least 12 weeks improved physical function and overall well-being in patients with FM. Although sustained physical activity was not associated with greater clinical benefit compared with unsustained physical activity, these findings also suggest that performing greater volumes of physical activity is not associated with worsening pain in FM. Future research is needed to determine the relationship between sustained MVPA participation and subsequent improvement in patient outcomes.
Authors: A L Stewart; C J Verboncoeur; B Y McLellan; D E Gillis; S Rush; K M Mills; A C King; P Ritter; B W Brown; W M Bortz Journal: J Gerontol A Biol Sci Med Sci Date: 2001-08 Impact factor: 6.053
Authors: Carol Ewing Garber; Bryan Blissmer; Michael R Deschenes; Barry A Franklin; Michael J Lamonte; I-Min Lee; David C Nieman; David P Swain Journal: Med Sci Sports Exerc Date: 2011-07 Impact factor: 5.411
Authors: William L Haskell; I-Min Lee; Russell R Pate; Kenneth E Powell; Steven N Blair; Barry A Franklin; Caroline A Macera; Gregory W Heath; Paul D Thompson; Adrian Bauman Journal: Med Sci Sports Exerc Date: 2007-08 Impact factor: 5.411
Authors: Kim Dupree Jones; Dianne Adams; Kerri Winters-Stone; Carol S Burckhardt Journal: Health Qual Life Outcomes Date: 2006-09-25 Impact factor: 3.186
Authors: Fernando Estévez-López; Cindy M Gray; Víctor Segura-Jiménez; Alberto Soriano-Maldonado; Inmaculada C Álvarez-Gallardo; Manuel J Arrayás-Grajera; Ana Carbonell-Baeza; Virginia A Aparicio; Manuel Delgado-Fernández; Manuel Pulido-Martos Journal: Qual Life Res Date: 2015-01-18 Impact factor: 4.147
Authors: Anthony S Kaleth; Silvia M Bigatti; James E Slaven; Nicholas Kelly; Dennis C Ang Journal: J Clin Rheumatol Date: 2022-01-01 Impact factor: 3.517
Authors: Isabella M Fuentes; Brittni M Jones; Aaron D Brake; Angela N Pierce; Olivia C Eller; Rachel M Supple; Douglas E Wright; Julie A Christianson Journal: Pain Date: 2021-06-01 Impact factor: 7.926
Authors: Chenchen Wang; Timothy McAlindon; Roger A Fielding; William F Harvey; Jeffrey B Driban; Lori Lyn Price; Robert Kalish; Anna Schmid; Tammy M Scott; Christopher H Schmid Journal: Trials Date: 2015-01-30 Impact factor: 2.279
Authors: Julia Bidonde; Angela J Busch; Candice L Schachter; Tom J Overend; Soo Y Kim; Suelen M Góes; Catherine Boden; Heather Ja Foulds Journal: Cochrane Database Syst Rev Date: 2017-06-21
Authors: Teresa Paolucci; Carlo Baldari; Manuela Di Franco; Dario Didona; Victor Reis; Mario Vetrano; Marco Iosa; Domenica Trifoglio; Federico Zangrando; Ennio Spadini; Vincenzo Maria Saraceni; Laura Guidetti Journal: Evid Based Complement Alternat Med Date: 2016-01-13 Impact factor: 2.629
Authors: Marcus Beasley; Gordon J Prescott; Graham Scotland; John McBeth; Karina Lovell; Phil Keeley; Philip C Hannaford; Deborah P M Symmons; Ross I R MacDonald; Steve Woby; Gary J Macfarlane Journal: RMD Open Date: 2015-02-18